CompletedNot Applicable

Video-observed Therapy for Active Tuberculosis: a Feasibility Study

Switzerland51 participantsStarted 2021-11-26

Plain-language summary

Tuberculosis (TB) is still present in Switzerland, and concerns mainly foreign-born subjects. Monitoring compliance to treatment by Directly Observed Therapy (DOT) is strongly encouraged by the World Health Organization (WHO). It is however time-consuming, costly and stigmatising. This study aims to examine the feasibility of monitoring compliance through a secured web platform and videos sent via an application on a cellphone, a concept known as vDOT (Video-observed therapy). The study aims to include all patients treated for tuberculosis is on our area during an 18 month period and monitor acceptance, compliance, and technical issues related to vDOT.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age above 16 years of age; providing informed consent (translators were used whenever necessary to ensure understanding of study and vDOT procedure); having a diagnosis of untreated active tuberculosis, irrespective of site of infection, confirmed by culture and/or Polymerase chain reaction test (PCR) and follow-up ensured by Geneva University Hospital. Exclusion Criteria: * refusal to participate, not fulfilling inclusion criteria

What they're measuring

Acceptance rate

Timeframe: Two weeks after starting TB treatment

Effective implementation rate

Timeframe: Two weeks after starting TB treatment

Trial details

NCT IDNCT06574529

SponsorLigue Pulmonaire Genevoise

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-18

View on ClinicalTrials.gov More Tuberculosis Active trials